US Broker Ratings

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Investor Ratings Indicate Promising Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is capturing investor attention in the biotechnology sector, with recent analyst ratings reflecting a solid upside potential for this commercial-stage company. Positioned at the forefront..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with a 10.53% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands as a prominent entity in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $5.3 billion, Teleflex’s..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the U.S. healthcare technology sector, has been making waves with its innovative approach to health insurance and technology-driven healthcare solutions. With..

DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.35% Upside in the Healthcare Sector

Investors looking to capture value in the healthcare sector might want to consider DaVita Inc. (NYSE: DVA), a key player in the medical care facilities industry, with a market capitalization..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant’s Potential Upside and Investment Appeal

McKesson Corporation (NYSE: MCK) stands tall in the healthcare sector as a prominent player in medical distribution, providing vital services across the United States and globally. With a market cap..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: An Exciting 61.92% Upside Potential for Biotech Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO) is making waves in the biotechnology sector with its innovative approach to addressing serious metabolic diseases. With a market capitalization of $3.82 billion and a..

Baxter International Inc. (BAX) Stock Analysis: Navigating a 30% Potential Upside Amidst Industry Challenges

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector with a significant presence in the medical instruments and supplies industry, is currently drawing investor attention due to its..

Becton, Dickinson and Company (BDX) Stock Analysis: Unlocking 12.82% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector for robust opportunities might find Becton, Dickinson and Company (NYSE: BDX) a compelling choice, especially considering its potential upside of 12.82%. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 74.95% Potential Upside in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands as a prominent figure in the healthcare sector, specifically within the medical devices industry. Known for its innovative solutions targeting obstructive sleep apnea..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

Waters Corporation (WAT) Stock Analysis: Navigating a 19% Potential Upside with Strategic Insights

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector’s diagnostics and research industry, continues to be a focal point for investors seeking opportunities within analytical workflow solutions. With a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the 80.69% Potential Upside Amidst Challenges

Moderna, Inc. (NASDAQ: MRNA) has been a focal point in the biotechnology sector, especially following its pivotal role in developing COVID-19 vaccines. As investors look towards the future, Moderna presents..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring Growth Potential Amid Healthcare Sector Dynamics

Bausch + Lomb Corporation (NYSE: BLCO) stands out in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Vaughan, Canada, this renowned eye health company has..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 29% Potential Upside with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, continues to capture investor interest with its innovative approach in the medical instruments and supplies industry. Headquartered..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Eyeing an 18.97% Upside with Robust Revenue Growth

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is gaining significant traction among investors. Headquartered in San Diego,..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 32.59% Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a key player in the healthcare information services sector, is attracting significant attention in the investment community. With a market capitalization of $6.54 billion, this..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 24% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is gaining attention with its promising 24.08% potential upside, according to analysts. With a focus on plasma-derived therapies and..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 24.28% Potential Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector with a robust focus on neurological and neurodegenerative diseases, presents an intriguing investment opportunity with a significant 24.28% potential upside...

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a Healthcare Giant with a Compelling 8.41% Upside

Universal Health Services, Inc. (NYSE: UHS), a formidable player in the healthcare sector, operates a network of acute care hospitals and behavioral health facilities across the United States. With a..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Partnerships

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, continues to capture investor interest with its innovative drug delivery platforms and robust growth metrics. Situated in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds